NASDAQ · Analyst Forecast

Filana Therapeutics, Inc. (FLNA) Stock Forecast & Price Target

$0.48 NASDAQ: FLNA Market Cap $23.23M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Filana Therapeutics, Inc. (FLNA), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Filana Therapeutics, Inc., the average estimate for 2030 earnings per share is −$0.48; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$0$0$01
2026$0$0$02
2027$0$0$01
2028$0$0$01
2029$0$0$01
2030$72.83M$72.83M$72.83M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$1.93−$1.93−$1.931
2026−$0.90−$0.86−$0.822
2027−$1.15−$1.15−$1.151
2028−$1.15−$1.15−$1.151
2029−$1.20−$1.20−$1.201
2030−$0.48−$0.48−$0.481

Filana Therapeutics, Inc. (FLNA) forecast — frequently asked questions

What are analysts forecasting for Filana Therapeutics, Inc.'s earnings?

The average analyst estimate for Filana Therapeutics, Inc. (FLNA) earnings per share in 2030 is -0.48, with individual estimates between -0.48 and -0.48.

How much revenue is Filana Therapeutics, Inc. expected to make?

Analysts forecast Filana Therapeutics, Inc. (FLNA) revenue of $72.83M in 2030, based on 1 published estimates.

How many analysts cover FLNA?

2 analysts contribute estimates for Filana Therapeutics, Inc. (FLNA). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.